Clinical Trial Update: Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on valbenazine for chorea in Huntington disease, reporting efficacy, safety, and tolerability results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Valbenazine (valbenazine)

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Chorea, Huntington | Phase 3 | Status: COMPLETED | Results posted: 2023-10-11